Welcome to the ICCS Website
The fundamental goal of the ICCS is to improve the quality of life and the life expectancy for all growing individuals with deficient bladder function, expressed as problems of storage and evacuation of urine. ICCS intends to approach this goal by increasing knowledge in all aspects of this problem area.
President's Message
Dear ICCS member
As you know by now, the St Louis conference, June 21-24 is held in collaboration with the Society for Research into Hydrocephalus and Spina Bifida (SRHSB), and will be (has been?) just great. Sixty-five quality abstracts have been accepted and local organiser (as well as ICCS General Secretary emeritus) Paul Austin, assisted by Scientific Chairman Søren Rittig and others, have been working overtime to make this a memorable event, both scientifically and socially. We will be assisted by the Mighty Mississippi and the ghost of America’s maybe greatest author, Mark Twain, who lived here. We should all follow his advice: ”when in doubt tell the truth”....
More...
Joint Congress of the International Children’s Continence Society and the Society for Research into Hydrocephalus and Spina Bifida (SRHSB)
21-24 June 2017
Abstract submission site: http://ce.mirasmart.com/ICCS2017
Registration is now open: http://www.cvent.com/d/0vqgr5
abstract-submission-guidelines
Make plans to come to the ICCS – Joint Congress of the International Children’s Continence Society and the Society for Research into Hydrocephalus and Spina Bifida (SRHSB) which is going to be held in St. Louis, Missouri, USA on the Campus of the Washington University School of Medicine.
World Bedwetting Day is 30 May 2017
Go to the link below to find out more.
http://www.worldbedwettingday.com
Industry cooperation statement
The ICCS is an independent, nonprofit organisation aimed at the advancement of research and healthcare. The ICCS Board and associated experts get no payment for their work. The running costs of the ICCS are covered by membership fees and unconditional educational grants from the medical industry.
Foremost among the latter are presently two companies: Ferring Pharmaceuticals and Coloplast, the cooperation with which we hereby gratefully acknowledge. The cooperation is regulated by contracts guaranteeing the independence and protection of both parts, and all matters of common interest are handled by liaison committees, with members from the ICCS and the two companies.
The ICCS members of the ICCS-Ferring liaison committee are Janet Chase, Søren Rittig and Johan Vande Walle. The ICCS members of the ICCS-Coloplast liaison committee are Mario De Gennaro, Søren Rittig and Anka Nieuwhof-Leppink.